| Beliefs about Depo-Provera among three groups of contraceptors. | |
| | |
MedLine Citation:
|
PMID: 8739515 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This article examines the beliefs about Depo-Provera held by three groups of contraceptors utilizing urban family planning clinics in the United States (n = 836). Patients choosing Depo-Provera, oral contraceptives, and Norplant were asked about their beliefs regarding Depo-Provera in the following four domains: effectiveness in preventing pregnancy, convenience, side-effects, and risk to health; and also for their perceptions regarding the physical discomfort and cost associated with the method. Findings reveal that patients choosing the pill and Norplant give Depo-Provera significantly lower ratings for both convenience and effectiveness than do Depo-Provera acceptors. Given the documented effectiveness of Depo-Provera, this is a potential cause for concern. Moreover, Norplant and pill choosers are most likely to hold inaccurate beliefs regarding both the cost of Depo-Provera, and certain side-effects associated with its use. Although more than half of all patients believe the Depo-Provera would cause menstrual changes and weight gain, it is noteworthy that the proportions are not higher, given their known association with the method. Knowledge about the likelihood of these side-effects is essential, particularly for those choosing Depo-Provera. Implications for physicians, counselors, and other family planning professionals are discussed. |
| | |
Authors:
|
L F Cushman; D Kalmuss; A R Davidson; S Heartwell; M Rulin |
Related Documents
:
|
8752225 - Measuring contraceptive effectiveness: a conceptual framework. 1109525 - Psychological antecedents to conception among abortion seekers. 17138775 - Young pregnant women's knowledge of modern intrauterine devices. 871635 - Erythema nodosum associated with pregnancy and oral contraceptives. 6312785 - In vivo and in vitro studies on the effect of sodium antagonists on the bladder in man ... 20331655 - A quasi-experimental study of maternal smoking during pregnancy and offspring academic ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Advances in contraception : the official journal of the Society for the Advancement of Contraception Volume: 12 ISSN: 0267-4874 ISO Abbreviation: Adv Contracept Publication Date: 1996 Mar |
Date Detail:
|
Created Date: 1996-10-10 Completed Date: 1996-10-10 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 8607435 Medline TA: Adv Contracept Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 43-52 Citation Subset: IM |
Affiliation:
|
Center for Population and Family Health, Columbia University School of Public Health, New York, NY 10032, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Community Health Services Contraceptive Agents, Female* Contraceptives, Oral Family Planning Services Female Health Knowledge, Attitudes, Practice Humans Levonorgestrel Medroxyprogesterone Acetate* / adverse effects, economics Menstruation Disturbances / chemically induced Patient Satisfaction* Pregnancy Risk Factors Urban Population Weight Gain |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptive Agents, Female; 0/Contraceptives, Oral; 71-58-9/Medroxyprogesterone Acetate; 797-63-7/Levonorgestrel |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Luteinizing hormone releasing hormone agonist for postpartum contraception.
Next Document: Sexual activity during and after pregnancy.